Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Hillerød – page 90

1 196 clinical trials in Hillerød, Denmark across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hillerød at a glance
1 196
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

1 196 trials in Hillerød

Open in trial search

Migraine

Not recruiting

Study on Galcanezumab for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

Investigational
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Galcanezumab
  • Sponsor:Eli Lilly & Co.

Migraine

Not recruiting

Study on Galcanezumab for Preventing Chronic Migraine in Adolescents Aged 12 to 17

Investigational
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Galcanezumab
  • Sponsor:Eli Lilly & Co.

Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Seralutinib
  • Sponsor:GB002 Inc.

Study on Extending Omalizumab Treatment Intervals for Adults with Well-Controlled Chronic Spontaneous Urticaria

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Omalizumab
  • Sponsor:Region Hovedstaden

Neoplasm malignant+2

Not recruiting

Study on Larotrectinib for Treating Children with Advanced Solid Tumors with NTRK Fusion

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Larotrectinib Sulfate
  • Sponsor:Bayer AG

Study Comparing Obinutuzumab and Venetoclax with Obinutuzumab and Chlorambucil for Untreated Chronic Lymphocytic Leukemia Patients with Other Health Conditions

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Chlorambucil
  • Sponsor:F. Hoffmann-La Roche AG

Study of Naxitamab and Sargramostim for High-Risk Neuroblastoma in Patients with Refractory Bone or Bone Marrow Disease

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Naxitamab
  • Sponsor:Y-mAbs Therapeutics A/S

Study of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Pleural mesothelioma

Not recruiting

Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Study on the Long-term Effects of EDG-5506 for Adults and Adolescents with Becker Muscular Dystrophy

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:EDG-5506
  • Sponsor:Edgewise Therapeutics Inc.

Study Comparing Aficamten and Metoprolol for Adults with Symptomatic Hypertrophic Cardiomyopathy

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Aficamten
  • Sponsor:Cytokinetics Inc.

Study on the Effects of Live Vaccines (Measles, Mumps, Rubella, BCG) on Immune System in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Saline
  • Sponsor:Gentofte Hospital

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Hillerød

What the registry says about research in the country

01 Gastroenterology Research

Ongoing clinical trials focusing on inflammatory bowel diseases, particularly investigating new treatments for Crohn's Disease and Ulcerative Colitis. Studies are evaluating the effectiveness of oral medications and biological therapies for managing moderate to severe cases.

  • Treatment optimization studies
  • Long-term disease management
  • Bowel wall healing assessment

Advanced therapeutic approaches aim to improve patient outcomes and quality of life.

02 Metabolic Disorders

Research initiatives targeting obesity and type 2 diabetes, with trials exploring innovative treatments combining medication with lifestyle modifications. Special focus on investigating new therapies for patients with concurrent weight management needs.

  • Weight management protocols
  • Diabetes control strategies
  • Combined therapeutic approaches

Studies aim to improve metabolic health outcomes through targeted interventions.

03 Cardiovascular Studies

Innovative research focusing on heart failure prevention and management of atrial fibrillation. Clinical trials are evaluating new medications and therapeutic combinations to reduce cardiovascular risks and improve patient outcomes.

  • Preventive cardiology
  • Stroke prevention
  • Cardiac treatment optimization

Advanced approaches in cardiovascular disease management and prevention.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.